0.36 USD
↘ 0.23 (39.00%)AT CLOSE (11:59 AM EDT)
Trinity Biotech plc
TRIBNASDAQ • USD
0.43
↗ 0.08 (21.31%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
0.43
↗ 0.08 (21.31%)
Market: CLOSED
TRIB is currently priced at $0.36. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. Notable factors include a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Jun 23, 2026.
Open?$0.43
High?$0.43
Low?$0.33
Prev. Close?$0.58
Volume?50.6M
Avg. Volume?N/A
VWAP?$0.64
Bid / Ask
Bid?$0.30 × 100
Ask?$0.40 × 100
Spread?$0.10
Midpoint?$0.35
Valuation & Ratios
Market Cap?11.7M
Shares Out?20.3M
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short Interest?239.7K
Days to Cover?1.5
Avg Daily Volume162.3K
Settlement Date2026-05-29